(Q38417709)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26829987%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

Intratumorally Establishing Type 2 Innate Lymphoid Cells Blocks Tumor Growth (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26829987%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26829987%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Jeong-Im Sin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26829987%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Neung H Park

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26829987%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Byungsuk Kwon

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26829987%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Juyang Kim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26829987%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Wonyoung Kim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26829987%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Hyun J Kim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26829987%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Hye-Jeong Choi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26829987%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Hong R Cho

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26829987%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

English

0 references

publication date

1 February 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26829987%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

published in

Journal of Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26829987%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26829987%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26829987%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

2410-2423

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26829987%20AND%20SRC:MED&resulttype=core&format=json

Experimental and clinical studies of cytokine gene-modified tumor cells

6 March 2020

cites work

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Cytokines in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Antibody-cytokine fusion proteins for treatment of cancer: engineering cytokines for improved efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Murine interleukin-4 displays potent anti-tumor activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Tumor cells secreting IL-13 but not IL-13Ralpha2 fusion protein have reduced tumorigenicity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Disease-associated functions of IL-33: the new kid in the IL-1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Transgenic expression of IL-33 activates CD8(+) T cells and NK cells and inhibits tumor growth and metastasis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

A novel method for procuring a large quantity of mature murine eosinophils in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Costimulatory molecule-targeted immunotherapy of cutaneous graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Improved survival and reduced vascular permeability by eliminating or blocking 12/15-lipoxygenase in mouse models of acute lung injury (ALI).

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Innate lymphoid cells--a proposal for uniform nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Chemokine receptor CXCR2 is transactivated by p53 and induces p38-mediated cellular senescence in response to DNA damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Opposing roles for HIF-1α and HIF-2α in the regulation of angiogenesis by mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Hypoxia-inducible factor-2α regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

TH2, allergy and group 2 innate lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Role of tissue protection in lethal respiratory viral-bacterial coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Pericytes: developmental, physiological, and pathological perspectives, problems, and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Senescence: a new weapon for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Chemokine signaling via the CXCR2 receptor reinforces senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

Mesenchymal stem cells regulate the proliferation of T cells via the growth-related oncogene/CXC chemokine receptor, CXCR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1501730

21 January 2018

Identifiers

DOI

10.4049/JIMMUNOL.1501730

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26829987%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference